482 IN VITRO COMBINATION THERAPY WITH TEGOBUVIR (GS-9190) IS HIGHLY EFFICIENT IN CURING CELLS FROM HCV REPLICON AND IN DELAYING/PREVENTING THE DEVELOPMENT OF ANTIVIRAL RESISTANCE

✍ Scribed by I. Vliegen; L. Delang; J. Paeshuyse; I.-H. Shih; G. Pürstinger; S. Bondy; W.A. Lee; W. Zhong; J. Neyts

• Book ID: 117379627
• Publisher: Elsevier Science
• Year: 2011
• Tongue: English
• Weight: 56 KB
• Volume: 54
• Category: Article
• ISSN: 0168-8278
• DOI: 10.1016/s0168-8278(11)60484-4